Artificial and bioartificial liver support: A review of perfusion treatment for hepatic failure patients

World Journal of Gastroenterology

Volumn 13, Issue 10, 2007, Pages 1516-1521

  Naruse, Katsutoshi ^a   Tang, Wei ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bioartificial liver support; Bioreactor; Blood purification therapy; Extracorporeal liver perfusion; Transgenic pig

Indexed keywords

AMINO ACID; AMMONIA;

AMMONIA BLOOD LEVEL; ARTIFICIAL LIVER; BIOARTIFICIAL LIVER; BIOREACTOR; CLINICAL TRIAL; COMA; DISEASE SEVERITY; HEMODIAFILTRATION; HUMAN; LIVER FAILURE; LIVER FUNCTION; LIVER PERFUSION; LIVER SUPPORT; LIVER TRANSPLANTATION; NONHUMAN; PATIENT SAFETY; PLASMAPHERESIS; REVIEW;

EID: 34247607633     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i10.1516     Document Type: Review

References (37)

1. Kiley JE, Pender JC, Welch HF, Welch CS. Ammonia intoxication treated by hemodialysis. N Engl J Med 1958; 259: 1156-1161
2. Schechter DC, Nealon TF Jr, Gibbon JH Jr. A simple extracorporeal device for reducing elevated blood ammonia levels; preliminary report. Surgery 1958; 44: 892-897
3. Lee C, Tink A. Exchange transfusion in hepatic coma: report of a case. Med J Aust 1958; 45: 40-42
4. Yatzidis H, Oreoploulos D, Triataphyllides D. Treatment of severe barbiturate poisoning. Lancet 1965; 2: 216-217
5. Chang TM. Haemoperfusions over microencapsulated adsorbent in a patient with hepatic coma. Lancet 1972; 2: 1371-1372
6. Burnell JM, Dawborn JK, Epstein RB, Gutman RA, Leinbach GE, Thomas ED, Volwiler W. Acute hepatic coma treated by cross-circulation or exchange transfusion. N Engl J Med 1967; 276: 935-943
7. Sabin S, Merritt JA. Treatment of hepatic coma in cirrhosis by plasmapheresis and plasma infusion (plasma exchange). Ann Intern Med 1968; 68: 1-7
8. Yamazaki Z, Kamai F, Ideduki Y, Inoue N. Extracorporeal methods of liver failure treatment. Biomater Artif Cells Artif Organs 1992; 15: 296-299
9. Henderson LW, Parker HR, Schroeder JP, Frigon R, Sanfelippo ML. Continuous low flow hemofiltration with sorbent regeneration of ultrafiltrate. Trans Am Soc Artif Intern Organs 1978; 24: 178-184
10. Opolon P, Rapin JR, Huguet C, Granger A, Delorme ML, Boschat M, Sausse A. Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD). Trans Am Soc Artif Intern Organs 1976; 22: 701-710
11. Knell AJ, Dukes DC. Dialysis procedures in acute liver coma. Lancet 1976; 2: 402-403
12. Ota K, Suzuki T, Ozaku Y, Hoshino T, Agishi T, Sugino N. Short-time hemodiafiltration using polymethylmethacrylate hemodiafilter. Trans Am Soc Artif Intern Organs 1978; 24: 454-457
13. Brunner G, Tegtmeier F. Enzymatic detoxification using lipophilic hollow-fiber membranes: I. Glucuronidation reactions. Artif Organs 1984; 8: 161-166
14. Lavin A, Sung C, Klibanov AM, Langer R. Enzymatic removal of bilirubin from blood: a potential treatment for neonatal jaundice. Science 1985; 230: 543-545
15. Yoshiba M0, Yamada H, Yoshikawa Y, Fujiwara K, Toda G, Oka H, Sanjo T, Yamazaki Z, Idezuki Y, Inoue N. Hemodiafiltration treatment of deep hepatic coma by protein passing membrane: case report. Artif Organs 1986; 10: 417-419
16. Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, Hickstein H, Korten G, Schmidt R, Hentschel J, Schulz M, Lohr M, Liebe S, Schareck W, Hopt UT. Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 2000; 6: 603-613
17. Kimoto S. The artificial liver: experiments and clinical application. Trans Am Soc Artif Intern Organs 1959; 5: 102-112
18. Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 1965; 162: 329-345
19. Abouna GM, Boehmig HG, Serrou B, Amemiya H, Martineau G. Long-term hepatic support by intermittent multi-species liver perfusions. Lancet 1970; 2: 391-396
20. Kawamura A, Jinkouzouki. Japanese J Artif Organ 2003; 32: 1-6
21. Ozawa K, Kamiyama Y, Kimura K, Ukikusa M, Kono Y, Yamato T, Shimahara Y, Nakatani T, Asano M, Irie R, Kawashima S, Uchida K, Ohtoshi M, Aoyama H, Hirai F, Yasuda K, Tobe T. The effects of heterologous liver cross-hemodialysis on adenylate energy charge of the remnant liver after major hepatic resection. Artif Organs 1982; 6: 447-452
22. Teraoka S, Honda H, Fuchinoue S, Oshima T, Agishi T, Ota T, et al. Ex vivo liver perfusion for acute liver failure. Saishin-Igaku 1987; 42: 1630-1639
23. Fox IJ, Langnas AN, Fristoe LW, Shaefer MS, Vogel JE, Antonson DL, Donovan JP, Heffron TG, Markin RS, Sorrell W. Successful application of extracorporeal liver perfusion: a technology whose time has come. Am J Gastroenterol 1993; 88: 1876-1881
24. Chari RS, Collins BH, Magee JC, DiMaio JM, Kirk AD, Harland RC, McCann RL, Platt JL, Meyers WC. Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med 1994; 331: 234-237
25. Neuhaus P, Blumhardt G. Extracorporeal liver perfusion: applications of an improved model for experimental studies of the liver. Int J Artif Organs 1993; 16: 729-739
26. Levy MF, Crippin J, Sutton S, Netto G, McCormack J, Curiel T, Goldstein RM, Newman JT, Gonwa TA, Banchereau J, Diamond LE, Byrne G, Logan J, Klintmalm GB. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus. Transplantation 2000; 69: 272-280
27. Xu H, Sharma A, Okabe J, Cui C, Huang L, Wei YY, Wan H, Lei Y, Logan JS, Levy MF, Byrne GW. Serologic analysis of anti-porcine endogenous retroviruses immune responses in humans after ex vivo transgenic pig liver perfusion. ASAIO J 2003; 49: 407-416
28. Matsumura KN, Guevara GR, Huston H, Hamilton WL, Rikimaru M, Yamasaki G, Matsumura MS. Hybrid bioartificial liver in hepatic failure: preliminary clinical report. Surgery 1987; 101: 99-103
29. Rozga J, Holzman MD, Ro MS, Griffin DW, Neuzil DF, Giorgio T, Moscioni AD, Demetriou AA. Development of a hybrid bioartificial liver. Ann Surg 1993; 217: 502-509; discussion 509-511
30. Gerlach JC, Encke J, Hole O, Muller C, Ryan CJ, Neuhaus P. Bioreactor for a larger scale hepatocyte in vitro perfusion. Transplantation 1994; 58: 984-988
31. Flendrig LM, Calise F, Di Florio E, Mancini A, Ceriello A, Santaniello W, Mezza E, Sicoli F, Belleza G, Bracco A, Cozzolino S, Scala D, Mazzone M, Fattore M, Gonzales E, Chamuleau RA. Significantly unproved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int J Artif Organs 1999; 22: 701-709
32. Mazariegos GV, Patzer JF 2nd, Lopez RC, Giraldo M, Devera ME, Grogan TA, Zhu Y, Fulmer ML, Amiot BP, Kramer DJ. First clinical use of a novel bioartificial liver support system (BLSS). Am J Transplant 2002; 2: 260-266
33. Uchino J, Tsuburaya T, Kumagai F, Hase T, Hamada T, Komai T, Funatsu A, Hashimura E, Nakamura K, Kon T. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans 1988; 34: 972-977
34. Naruse K, Sakai Y, Lei G, Sakamoto Y, Kobayashi T, Puliatti C, Aronica G, Morale W, Leone F, Qiang S, Ming SG, Ming S, Li Z, Chang SJ, Suzuki M, Makuuchi M. Efficacy of nonwoven fabric bioreactor immobilized with porcine hepatocytes for ex vivo xenogeneic perfusion treatment of liver failure in dogs. Artif Organs 2001; 25: 273-280
35. Naruse K, Sakai Y, Guo L, Natori T, Shindoh J, Karasawa Y, Iida Y, Kojima K, Michishita. K, Makuuchi M. Development of a new extracorporeal whole-liver perfusion system. J Artif Organs 2003; 6: 211-217
36. Naruse K, Sakai Y, Natori T, Guo L, Shindoh J, Iida Y, Michishita K, Karasawa Y, Kojima K, Makuuchi M. Xenogeneic direct hemoperfusion using whole swine liver for liver failure in dogs. J Surg Res 2003; 111: 229-235
37. Naruse K, Nagashima H, Sakai Y, Kokudo N, Makuuchi M. Development and perspectives of perfusion treatment for liver failure. Surg Today 2005; 35: 507-517